These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 729102)

  • 1. Bioavailability of powdered inclusion compounds of nonsteroidal antiinflammatory drugs with beta-cyclodextrin in rabbits and dogs.
    Nambu N; Shimoda M; Takahashi Y; Ueda H; Nagai T
    Chem Pharm Bull (Tokyo); 1978 Oct; 26(10):2952-6. PubMed ID: 729102
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhanced oral bioavailability of antiinflammatory drug flurbiprofen in rabbits by tri-O-methyl-beta-cyclodextrin complexation.
    Otagiri M; Imai T; Uekama K
    J Pharmacobiodyn; 1982 Dec; 5(12):1027-9. PubMed ID: 7169606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of bioavailability of cinnarizine from its beta-cyclodextrin complex on oral administration with DL-phenylalanine as a competing agent.
    Tokumura T; Tsushima Y; Kayano M; Machida Y; Nagai T
    J Pharm Sci; 1985 Apr; 74(4):496-7. PubMed ID: 3999017
    [No Abstract]   [Full Text] [Related]  

  • 4. Interaction of tri-O-methyl-beta-cyclodextrin with drugs. II. Enhanced bioavailability of ketoprofen in rats when administered with tri-O-methyl-beta-cyclodextrin.
    Nakai Y; Yamamoto K; Terada K; Horibe H; Ozawa K
    Chem Pharm Bull (Tokyo); 1983 Oct; 31(10):3745-7. PubMed ID: 6671012
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of inclusion of nonsteroidal antiinflammatory drugs with beta-cyclodextrin on the irritation to stomach of rats upon oral administration.
    Nambu N; Kikuchi K; Kikuchi T; Takahashi Y; Ueda H; Nagai T
    Chem Pharm Bull (Tokyo); 1978 Dec; 26(12):3609-12. PubMed ID: 747846
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhanced absorption of phenobarbital from suppositories containing phenobarbital-beta-cyclodextrin inclusion complex.
    Iwaoku R; Arimori K; Nakano M; Uekama K
    Chem Pharm Bull (Tokyo); 1982 Apr; 30(4):1416-21. PubMed ID: 7105261
    [No Abstract]   [Full Text] [Related]  

  • 7. Simulation of pharmacokinetic behaviour of drug-cyclodextrin complexes.
    Habon I; Fritsch S; Szejtli J
    Pharmazie; 1984 Dec; 39(12):830-4. PubMed ID: 6531392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optical studies of drug-protein complexes. 3. Interaction of flufenamic acid and other N-arylanthranilates with serum albumin.
    Chignell CF
    Mol Pharmacol; 1969 Sep; 5(5):455-62. PubMed ID: 5823761
    [No Abstract]   [Full Text] [Related]  

  • 9. Excretion and metabolism of a nonsteroidal antiinflammatory agent, 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxanilide 1,1-dioxide, in rat, dog, monkey, and man.
    Chiaini J; Wiseman EH; Lombardino JG
    J Med Chem; 1971 Dec; 14(12):1175-7. PubMed ID: 5000562
    [No Abstract]   [Full Text] [Related]  

  • 10. [Improvement in pharmacological properties of thiopental by gamma-cyclodextrin complexation].
    Arimori K; Iwaoku R; Nakano M; Uemura Y; Otagiri M; Uekama K
    Yakugaku Zasshi; 1983 May; 103(5):553-8. PubMed ID: 6644545
    [No Abstract]   [Full Text] [Related]  

  • 11. Bioavailability of flufenamic acid in hard and soft gelatin capsules.
    Angelucci L; Petrangeli B; Celletti P; Favilli S
    J Pharm Sci; 1976 Mar; 65(3):455-6. PubMed ID: 1263104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal absorption of 14C-labelled beta-cyclodextrin in rats.
    Szejtli J; Gerlóczy A; Fónagy A
    Arzneimittelforschung; 1980; 30(5):808-10. PubMed ID: 7190424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dissolution profiles of powdered inclusion compounds of sulfonamide drugs with beta-cyclodextrin].
    Chen JY; Tsai WY
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1989 Apr; 5(4):206-11. PubMed ID: 2769826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Improvement of bioavailability of menaquinone-4 by dimethyl-beta-cyclodextrin complexation following oral administration].
    Horiuchi Y; Kikuchi M; Hirayama F; Uekama K; Ueno M; Ijitsu T
    Yakugaku Zasshi; 1988 Nov; 108(11):1093-100. PubMed ID: 3251020
    [No Abstract]   [Full Text] [Related]  

  • 15. The bioavailability of flufenamic acid and its dissolution rate from capsules.
    Kaniwa N; Ogata H; Aoyagi N; Shibazaki T; Ejima A; Watanabe Y; Motohashi K; Sasahara K; Nakajima E; Morioka T; Nitanai T
    Int J Clin Pharmacol Ther Toxicol; 1983 Feb; 21(2):56-63. PubMed ID: 6840926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of oral bioavailability of spironolactone by beta- and gamma-cyclodextrin complexations.
    Seo H; Tsuruoka M; Hashimoto T; Fujinaga T; Otagiri M; Uekama K
    Chem Pharm Bull (Tokyo); 1983 Jan; 31(1):286-91. PubMed ID: 6850944
    [No Abstract]   [Full Text] [Related]  

  • 17. [Enhanced bioavailability of phenytoin by beta-cyclodextrin complexation (author's transl].
    Tsuruoka M; Hashimoto T; Seo H; Ichimasa S; Ueno O; Fujinaga T; Otagiri M; Uekama K
    Yakugaku Zasshi; 1981 Apr; 101(4):360-7. PubMed ID: 7288580
    [No Abstract]   [Full Text] [Related]  

  • 18. [Enhanced bioavailability of acetohexamide by beta-cyclodextrin complexation (author's transl)].
    Uekama K; Matsuo N; Hirayama F; Ichibagase H; Arimori K; Tsubaki K; Satake K
    Yakugaku Zasshi; 1980 Sep; 100(9):903-9. PubMed ID: 7218151
    [No Abstract]   [Full Text] [Related]  

  • 19. Enhancement of specific biological activity of dipyridamole by complexation with beta-cyclodextrin.
    Fregnan GB; Bertè F
    Pharmacology; 1990; 40(2):96-102. PubMed ID: 2345776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-steroidal and analgesic therapy in the elderly.
    Schlegel SI; Paulus HE
    Clin Rheum Dis; 1986 Apr; 12(1):245-73. PubMed ID: 2872994
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.